SNCA and Parkinson disease: The A53T mutation of the SNCA gene is one of the most studied mutations in PD, and rats carrying the A53T mutation and overexpression of alpha synuclein exhibit a phenotype resembling PD, which can be prevented through CRISPR/Cas9 mediated deletion of the mutant gene (Yoon et al., 2022).